At Huvepharma® we continue to invest and expand in our pursuit of excellence. That requires staying one step ahead in terms of technology, innovation and knowledge.
We have more than half a century of expertise in the fermentation and manufacturing of human and animal health and nutritional products. Our growth is both organic and through acquisitions. We have successfully integrated products, facilities and know-how from numerous prestigious brands across many of the industries we work in and continue to look for other strategic acquisitions to help us create a balanced product portfolio and achieve our goals.
At Huvepharma® we constantly strive to deliver what you, our customers, need. That requires staying one step ahead in terms of technology, innovation and knowledge. We continue to invest and expand in our pursuit of excellence.
New R&D facilities and laboratories have been built, our fermentation capacity has doubled, construction of a new vaccine plant has started, and our warehousing facilities will continue to be upgraded with the very latest IT logistic technology.
In the future we will continue to introduce new products, such as vaccines, to our expanding portfolio and, where suitable, extend our product offerings to include more applications into other species.
While we continue to develop our range of antibiotic products, taking into account global concerns, Huvepharma® is also committed to researching alternative solutions and new disease prevention measures for effective disease management and treatment.
We have more than half a century of expertise in the fermentation and manufacturing of human and animal health and nutritional products, our goal is to become an industrial leader, playing a significant role in advancing the animal health and human pharmaceutical industries. With our global organisation, we aim to reach and improve the performance of every animal in the production chain.
